Shares of Core Scientific, Inc. (NASDAQ:CORZ – Get Free Report) have received an average recommendation of “Moderate Buy” from the twenty ratings firms that are currently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, sixteen have given a buy rating and two have assigned a strong buy rating to the company. The average 12-month price objective among brokers that have issued a report on the stock in the last year is $32.1806.
Several equities analysts recently weighed in on CORZ shares. Lucid Cap Mkts upgraded shares of Core Scientific to a “strong-buy” rating in a report on Friday, June 12th. Sanford C. Bernstein restated an “outperform” rating and set a $32.00 price objective on shares of Core Scientific in a research note on Wednesday, June 3rd. B. Riley Financial upped their price objective on shares of Core Scientific from $33.00 to $42.00 and gave the company a “buy” rating in a report on Monday. Jefferies Financial Group increased their price objective on shares of Core Scientific from $24.00 to $37.00 and gave the stock a “buy” rating in a research note on Thursday, May 14th. Finally, Keefe, Bruyette & Woods raised shares of Core Scientific from a “market perform” rating to an “outperform” rating and raised their target price for the stock from $25.00 to $28.00 in a report on Thursday, July 30th.
Get Our Latest Report on Core Scientific
Insider Buying and Selling
Hedge Funds Weigh In On Core Scientific
Several institutional investors and hedge funds have recently modified their holdings of CORZ. Handelsbanken Fonder AB boosted its stake in shares of Core Scientific by 0.7% in the second quarter. Handelsbanken Fonder AB now owns 94,500 shares of the company’s stock worth $2,418,000 after buying an additional 700 shares during the last quarter. GAMMA Investing LLC raised its position in Core Scientific by 34.5% during the second quarter. GAMMA Investing LLC now owns 3,049 shares of the company’s stock valued at $78,000 after acquiring an additional 782 shares in the last quarter. Avior Wealth Management LLC purchased a new position in Core Scientific during the second quarter valued at approximately $264,000. Harbor Investment Advisory LLC acquired a new position in Core Scientific in the second quarter valued at approximately $136,000. Finally, CoreCap Advisors LLC acquired a new position in Core Scientific in the second quarter valued at approximately $36,000.
Core Scientific Stock Performance
Shares of CORZ stock opened at $21.77 on Thursday. Core Scientific has a fifty-two week low of $13.14 and a fifty-two week high of $30.46. The firm has a market capitalization of $7.00 billion, a PE ratio of -4.93 and a beta of 5.59. The stock’s 50-day simple moving average is $24.84 and its 200-day simple moving average is $20.93.
Core Scientific (NASDAQ:CORZ – Get Free Report) last released its earnings results on Tuesday, July 28th. The company reported ($3.32) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($3.26). The company had revenue of $164.20 million during the quarter, compared to analysts’ expectations of $144.83 million. Sell-side analysts forecast that Core Scientific will post -1.36 earnings per share for the current year.
Core Scientific Company Profile
Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.
Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.
See Also
- Five stocks we like better than Core Scientific
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Receive News & Ratings for Core Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
